Velikova G, Morden JP, Haviland JS, Emery C, et al. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomis Lancet Oncol 2023 Nov 2:S1470-2045(23)00460.
PMID: 37926100